Literature DB >> 22112491

The molecular pathology of sarcomas.

Martin Powers1, Wei Zhang, Dolores Lopez-Terrada, Bogdan A Czerniak, Alexander J Lazar.   

Abstract

Sarcomas are rare malignancies of mesenchymal lineage with more than 100 specific types and many benign potential mimics. In situ and precursor lesions are generally not described and thus much of molecular pathology in this field concentrates on molecular diagnosis, prognosis and determination of therapeutic targets. This chapter discusses the applications of molecular methodologies that provide insight into pathogenesis of sarcoma, and of molecular methods which are currently applied to, or will likely soon influence, the clinical management of this complex array of tumors.

Entities:  

Mesh:

Year:  2010        PMID: 22112491     DOI: 10.3233/CBM-2011-0170

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  7 in total

1.  Genetic polymorphisms in COL18A1 influence the development of osteosarcoma.

Authors:  Zhihao Guo; Tianji Zhang; Juntao Wu; Hongwei Wang; Xiaotan Liu; Linqiang Tian
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  Association between XRCC3 Thr241Met polymorphism and risk of osteosarcoma in a Chinese population.

Authors:  Libin Yang; Yongbo An; Guodong Wang; Tan Lu; Shujuan Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Role of five small nucleotide polymorphisms in the VEGF gene on the susceptibility to osteosarcoma and overall survival of patients.

Authors:  Jian-Qiang Liu; Xia Bai; DE-Chen Duan; Ai-Xia Dou
Journal:  Oncol Lett       Date:  2015-06-19       Impact factor: 2.967

4.  Single nucleotide polymorphisms in VEGF gene are associated with an increased risk of osteosarcoma.

Authors:  Zhang Tie; Rui Bai; Zhongwen Zhai; Gang Zhang; Hong Zhang; Zhenqun Zhao; Deshan Zhou; Wanlin Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

5.  Genetic polymorphisms of interleukin-1 beta and osteosarcoma risk.

Authors:  Yu He; XinJun Liang; ChunQing Meng; ZengWu Shao; Yong Gao; Qiang Wu; JianXiang Liu; Hong Wang; ShuHua Yang
Journal:  Int Orthop       Date:  2014-05-31       Impact factor: 3.075

6.  Association of interleukin 16 gene polymorphisms and plasma IL16 level with osteosarcoma risk.

Authors:  Yu-Jin Tang; Jun-Li Wang; Ke-Gong Xie; Chang-Gong Lan
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

7.  Association of common variants in MTAP with susceptibility and overall survival of osteosarcoma: a two-stage population-based study in Han Chinese.

Authors:  Liqiang Zhi; Dan Liu; Stephen G Wu; Tianqing Li; Guanghui Zhao; Bo Zhao; Meng Li
Journal:  J Cancer       Date:  2016-10-25       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.